Pre-Application Webinar for NOT-CA-25-004, Notice of Special Interest (NOSI): Administrative Supplements for Assessing Capacity to Address Obesity for Cancer Prevention and Control
Notice Number:
NOT-CA-25-008

Key Dates

Release Date:

November 8, 2024

Related Announcements

  • October 29, 2024 - Notice of Special Interest (NOSI): Administrative Supplements for Assessing Capacity to Address Obesity for Cancer Prevention and Control. See NOT-CA-25-004

Issued by

National Cancer Institute (NCI)

Purpose

NCI will hold a pre-application webinar on November 18, 2024, from 1:00 - 2:00 PM ET for the Notice of Special Interest (NOSI) NOT-CA-25-004 entitled "Administrative Supplements for Assessing Capacity to Address Obesity for Cancer Prevention and Control."

NCI staff members involved in this NOSI will provide orientation and technical assistance to potential applicants to the above-referenced NOSI by explaining the goals and objectives for the NOSI and answer questions from webinar attendees.

Potential applicants are encouraged to submit questions when registering for the pre-application webinar or via email to [email protected] by 12:00 PM ET on November 13, 2024.

Webinar Information

To join the Webinar, pre-registration is required through Zoom.

To register for the November 18, 2024, webinar, please go to  https://nih.zoomgov.com/meeting/register/vJItcu2qpzIuGYLTUEbnP0vI1flRZ9QdP5A

Specific webinar information will be provided upon registration.

Participation in this webinar, although highly encouraged, is optional and is not required for the submission of an application in response to NOT-CA-25-004.

The webinar will be recorded for those who are not able to participate in the live event. The webinar recording will be posted on the following website approximately two weeks after the live event at https://epi.grants.cancer.gov/events/#past.

Inquiries

Please direct all inquiries to:

Please direct all inquiries to:

David Berrigan, PhD, MPH 
National Cancer Institute (NCI)
Telephone: 240-276-6752
Email: [email protected]

Jill Reedy, PhD, MPH, RDN

National Cancer Institute (NCI)
Telephone: 240-276-6812
Email: [email protected]